Age group (years) | Observed cases | Expected cases | SIR | 95% CI | Chi- square test P- value | Equivalent annual incidence rates/ 100,000 |
---|---|---|---|---|---|---|
65+ | Â | Â | Â | Â | Â | Â |
Males | 69 | 106 | 65.2 | 50.7 – 82.6 | <0.001** | 30.85 |
Females | 101 | 150 | 67.1 | 54.7 – 81.6 | <0.001** | 31.33 |
65+ All | 170 | 256 | 66.4 | 56.8 – 77.2 | <0.001** | 31.13 |
Males | Â | Â | Â | Â | Â | Â |
0–4 | 36 | 30 | 118.4 | 82.9 – 164.1 | 0.310 | 40.04 |
5–34 | 37 | 25 | 150.2 | 105.7 – 207.2 | 0.013* | 5.79 |
35–49 | 37 | 39 | 95.0 | 66.8 – 131.1 | 0.757 | 9.98 |
50–64 | 42 | 44 | 95.8 | 69.0 – 129.56 | 0.780 | 14.03 |
65–74 | 31 | 41 | 74.8 | 50.8 – 106.3 | 0.105 | 22.74 |
75+ | 38 | 65 | 58.8 | 41.6 – 80.8 | <0.001** | 43.49 |
Females | Â | Â | Â | Â | Â | Â |
0–4 | 27 | 18 | 152.2 | 100.2 – 221.8 | 0.028 | 31.41 |
5–34 | 32 | 16 | 204.8 | 140.0 – 289.4 | <0.001* | 5.05 |
35–49 | 26 | 20 | 129.4 | 84.4 – 189.8 | 0.188 | 6.62 |
50–64 | 35 | 42 | 83.9 | 58.4 – 116.8 | 0.298 | 11.16 |
65–74 | 26 | 43 | 60.3 | 39.3 – 88.4 | 0.009** | 15.74 |
75+ | 75 | 107 | 70.0 | 55.1 – 87.8 | 0.002** | 47.72 |